Amivantamab plus lazertinib versus osimertinib as first-line treatment in EGFR-mutated advanced non-small cell lung cancer: MARIPOSA Asian subset
Amivantamab-lazertinib demonstrated superior progression-free survival versus osimertinib in Asian participants, with a tolerable safety profile. These results were consistent with those in the overall population.
Authors
- Shingo Matsumoto (ORCID: https://orcid.org/0000-0003-2698-0839)
- Shun Lü (ORCID: https://orcid.org/0000-0001-8833-7262)
- Adlinda Alip (ORCID: https://orcid.org/0000-0003-4744-4533)
- Melissa Martínez (ORCID: https://orcid.org/0000-0003-2683-1243)
- Pongwut Danchaivijitr (ORCID: https://orcid.org/0000-0002-8230-5232)
- Baogang Liu
- Hiroshige Yoshioka (ORCID: https://orcid.org/0000-0001-7724-0481)
- Hidetoshi Hayashi (ORCID: https://orcid.org/0000-0001-8787-5587)
- Koichi Azuma (ORCID: https://orcid.org/0000-0001-5040-5856)
- Mehmet Alı Nahıt Şendur (ORCID: https://orcid.org/0000-0001-7021-6139)
- James Chih‐Hsin Yang (ORCID: https://orcid.org/0000-0002-5586-5138)
- Ying Cheng (ORCID: https://orcid.org/0000-0001-9908-597X)
- Patrapim Sunpaweravong (ORCID: https://orcid.org/0000-0001-9787-270X)
- Joshua Bauml (ORCID: https://orcid.org/0000-0003-4193-841X)
- Byoung Chul Cho (ORCID: https://orcid.org/0000-0002-5562-270X)
- Gee‐Chen Chang (ORCID: https://orcid.org/0000-0002-1802-417X)
- Yichuan Xia
- Chien‐Chung Lin (ORCID: https://orcid.org/0000-0002-4739-5631)
- Hailin Xiong
- Kumar Prabhash
- Yun-Gyoo Lee
- Jong-Seok Lee
- Seema Sethi
- Se-Hoon Lee
- Soon Hin How
Institutions
- Kurume University (JP)
- Kansai Medical University (JP)
- Prince of Songkla University (TH)
- Johnson & Johnson (United States) (US)
- Siriraj Hospital (TH)
- Ankara University (TR)
- Harbin Medical University (CN)
- National Taiwan University (TW)
- Yonsei University (KR)
- Tata Memorial Hospital (IN)
- Samsung Medical Center (KR)
- Shanghai Chest Hospital (CN)
- Seoul National University Bundang Hospital (KR)
- University of Malaya (MY)
- International Islamic University Malaysia (MY)
- Jilin Province Tumor Hospital (CN)
- Memorial Ankara Hospital (TR)
- Kangbuk Samsung Hospital (KR)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Chung Shan Medical University Hospital (TW)
- Başkent University Hospital (TR)
- Huizhou Central People's Hospital (CN)
- Chest Hospital, Ministry of Health and Welfare (TW)
- National Cancer Center Hospital East (JP)
- National Cheng Kung University Hospital (TW)
- Sungkyunkwan University (KR)
- Chung Shan Medical University (TW)
- Kindai University (JP)
Publication Details
- Journal
- Lung Cancer
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1016/j.lungcan.2025.108496
- Citations
- 4
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 6.07